Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users.
Drug-resistant tuberculosis remains a persistent public health threat. Maximizing successful treatment completion is a global health priority and a focus of the End TB strategy. Despite the implementation of programmatic management for drug-resistant tuberculosis in Ethiopia, there is limited unders...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLOS Global Public Health |
Online Access: | https://doi.org/10.1371/journal.pgph.0004110 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823856675222716416 |
---|---|
author | Ahmed Reshid Tusho Sheila Theresa Mokoboto-Zwane |
author_facet | Ahmed Reshid Tusho Sheila Theresa Mokoboto-Zwane |
author_sort | Ahmed Reshid Tusho |
collection | DOAJ |
description | Drug-resistant tuberculosis remains a persistent public health threat. Maximizing successful treatment completion is a global health priority and a focus of the End TB strategy. Despite the implementation of programmatic management for drug-resistant tuberculosis in Ethiopia, there is limited understanding of the barriers related to successful treatment completion among Ethiopian patients. A qualitative study that is explorative, descriptive and contextual in nature was conducted to explore and describe the views and lived experiences of previously treated drug-resistant tuberculosis patients to gain an in-depth understanding of barriers to the successful completion of drug-resistant tuberculosis treatment. Six focus group discussion sessions with 42 purposively selected drug-resistant tuberculosis patients with previous treatment history and on retreatment regimens were conducted. The seven prominent themes revealed were: drug-related challenges encompassing adverse events and the lengthy treatment duration; clinical hurdles such as delayed consultation following prolonged illness, diagnostic delays, and suboptimal dosages; psycho-emotional difficulties including emotional trauma and facing stigma from both the community and healthcare professionals; socio-economic constraints; service-related issues such as interruptions in monitoring tests, inadequate follow-up, and accessibility barriers; patient-related factors such as a false sense of recovery and reverting to previously quit habits; and provider-related issues such as lack of responsiveness and ineffective communication. Addressing these factors demands policy-level decisions and programmatic guidance at the national level based on best practices, as well as good programmatic implementation from actors through regional and health facility-level structures. |
format | Article |
id | doaj-art-82f2d3a1373649deb70109a9ace0772d |
institution | Kabale University |
issn | 2767-3375 |
language | English |
publishDate | 2025-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLOS Global Public Health |
spelling | doaj-art-82f2d3a1373649deb70109a9ace0772d2025-02-12T05:48:26ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752025-01-0152e000411010.1371/journal.pgph.0004110Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users.Ahmed Reshid TushoSheila Theresa Mokoboto-ZwaneDrug-resistant tuberculosis remains a persistent public health threat. Maximizing successful treatment completion is a global health priority and a focus of the End TB strategy. Despite the implementation of programmatic management for drug-resistant tuberculosis in Ethiopia, there is limited understanding of the barriers related to successful treatment completion among Ethiopian patients. A qualitative study that is explorative, descriptive and contextual in nature was conducted to explore and describe the views and lived experiences of previously treated drug-resistant tuberculosis patients to gain an in-depth understanding of barriers to the successful completion of drug-resistant tuberculosis treatment. Six focus group discussion sessions with 42 purposively selected drug-resistant tuberculosis patients with previous treatment history and on retreatment regimens were conducted. The seven prominent themes revealed were: drug-related challenges encompassing adverse events and the lengthy treatment duration; clinical hurdles such as delayed consultation following prolonged illness, diagnostic delays, and suboptimal dosages; psycho-emotional difficulties including emotional trauma and facing stigma from both the community and healthcare professionals; socio-economic constraints; service-related issues such as interruptions in monitoring tests, inadequate follow-up, and accessibility barriers; patient-related factors such as a false sense of recovery and reverting to previously quit habits; and provider-related issues such as lack of responsiveness and ineffective communication. Addressing these factors demands policy-level decisions and programmatic guidance at the national level based on best practices, as well as good programmatic implementation from actors through regional and health facility-level structures.https://doi.org/10.1371/journal.pgph.0004110 |
spellingShingle | Ahmed Reshid Tusho Sheila Theresa Mokoboto-Zwane Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users. PLOS Global Public Health |
title | Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users. |
title_full | Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users. |
title_fullStr | Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users. |
title_full_unstemmed | Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users. |
title_short | Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users. |
title_sort | treatment completion of drug resistant tuberculosis in ethiopia a perspective from healthcare users |
url | https://doi.org/10.1371/journal.pgph.0004110 |
work_keys_str_mv | AT ahmedreshidtusho treatmentcompletionofdrugresistanttuberculosisinethiopiaaperspectivefromhealthcareusers AT sheilatheresamokobotozwane treatmentcompletionofdrugresistanttuberculosisinethiopiaaperspectivefromhealthcareusers |